Literature DB >> 22153723

Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot.

Peter C Chen1, Maggie S Sager, David Zurakowski, Frank A Pigula, Christopher W Baird, John E Mayer, Pedro J Del Nido, Sitaram M Emani.   

Abstract

OBJECTIVE: We sought to identify predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot.
METHODS: A retrospective review of 227 patients with tetralogy of Fallot who underwent stented bioprosthetic pulmonary valve replacement at Children's Hospital Boston between 1994 and 2009 was performed. Patient and valve characteristics were assessed as potential predictors of structural valve deterioration by using univariate and multivariable analysis. Freedom from pulmonary valve reintervention and structural valve deterioration were determined by using Kaplan-Meier analysis.
RESULTS: Two hundred twenty-nine pulmonary valve replacement operations were performed, with no early mortalities. Freedom from reintervention and structural valve deterioration were 94% (95% confidence interval, 87%-100%) and 74% (95% confidence interval, 63%-85%) at 5 years, respectively, and median time to reintervention was 6.4 years (range, 2-10.1 years). Younger age and higher indexed valve internal diameter were predictors of reduced time to structural valve deterioration. Among patients aged less than 20 years at the time of pulmonary valve replacement, indexed valve internal diameter was a significant predictor of increased risk of structural valve deterioration. Valve manufacturer was not a significant predictor of structural valve deterioration.
CONCLUSIONS: Younger age at the time of pulmonary valve replacement and valve oversizing in patients less than 20 years of age at the time of pulmonary valve replacement were significant predictors of structural valve deterioration and could potentially affect the timing of pulmonary valve replacement and the extent of valve oversizing in small children. No statistically significant difference in valve performance was seen between bioprosthetic valve types at short-term follow-up.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22153723     DOI: 10.1016/j.jtcvs.2011.10.079

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

1.  A geometrically adaptable heart valve replacement.

Authors:  Sophie C Hofferberth; Mossab Y Saeed; Lara Tomholt; Matheus C Fernandes; Christopher J Payne; Karl Price; Gerald R Marx; Jesse J Esch; David W Brown; Jonathan Brown; Peter E Hammer; Richard W Bianco; James C Weaver; Elazer R Edelman; Pedro J Del Nido
Journal:  Sci Transl Med       Date:  2020-02-19       Impact factor: 17.956

Review 2.  A look at recent improvements in the durability of tissue valves.

Authors:  Takahiro Nishida; Ryuji Tominaga
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-01-24

Review 3.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

4.  Immunoproteomic Identification of Noncarbohydrate Antigens Eliciting Graft-Specific Adaptive Immune Responses in Patients with Bovine Pericardial Bioprosthetic Heart Valves.

Authors:  Katherine V Gates; Qi Xing; Leigh G Griffiths
Journal:  Proteomics Clin Appl       Date:  2018-12-19       Impact factor: 3.494

Review 5.  Valvular heart disease in congenital heart disease: a narrative review.

Authors:  Joshua M Saef; Joanna Ghobrial
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

6.  Management of pulmonic regurgitation and right ventricular dysfunction in the adult with repaired tetralogy of fallot.

Authors:  Elisa Zaragoza-Macias; Karen K Stout
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

7.  Pulmonary Valve Replacement With a Trifecta Valve Is Associated With Reduced Transvalvular Gradient.

Authors:  Brian C Gulack; Ehsan Benrashid; Robert D B Jaquiss; Andrew J Lodge
Journal:  Ann Thorac Surg       Date:  2016-08-25       Impact factor: 4.330

Review 8.  Pulmonary valve replacement after repaired Tetralogy of Fallot.

Authors:  Hideki Tatewaki; Akira Shiose
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-19

9.  Mid-term outcomes of mechanical pulmonary valve replacement: a single-institutional experience of 396 patients.

Authors:  Maziar Gholampour Dehaki; Alwaleed Al-Dairy; Yousef Rezaei; Gholamreza Omrani; Amir Hossein Jalali; Hoda Javadikasgari; Mahyar Gholampour Dehaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-09-12

Review 10.  Recent Development in Pulmonary Valve Replacement after Tetralogy of Fallot Repair: The Emergence of Hybrid Approaches.

Authors:  Tariq Suleiman; Clifford J Kavinsky; Clare Skerritt; Damien Kenny; Michael N Ilbawi; Massimo Caputo
Journal:  Front Surg       Date:  2015-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.